TLXEarningsglobenewswire

Telix 2025 Half-Year Results: Strong commercial performance enables investment for long-term growth

Sentiment:Positive (70)

Summary

MELBOURNE, Australia and INDIANAPOLIS, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the half-year ended 30 June 2025. All figures are in USD unless stated otherwise.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 21, 2025 by globenewswire